19 Apr, 2020

  • Features of elearn platform
  • Hydroxychloroquine does not reduce viral load, randomised trial shows (Science & Technology) (Treatment for COVID-19)
  • Will convalescent plasma help COVID-19 patients? (Science & Technology) - (Treatment for COVID-19)
  • RT­PCR only confirmatory test, says govt. (Science & Technology) - (Treatment for COVID-19)
  • Govt. nod mandatory for FDI from neighboring countries (Indian Economy) - (FDI policy of India)
  • Question of the day (Polity & Governance)

Prelims Quiz

    Solution.

    • Total Marks 0
    • Total Scored 0
    • Total Attempted 0
    • Total Correct 0
    • Total Wrong 0
    • Total Not Attempted 0
    0%
    Description

    Hydroxychloroquine does not reduce viral load, randomised trial shows

    Results of a randomised, control trial using hydroxychloroquine drug in 150 COVID­19 patients show that

    the drug does not reduce the vi­ral load even on day 28 - drug was not able to suppress viral replication.

    Quicker alleviation of clin­ical symptoms, possibly through an­ti­-inflammatory properties and im­provement in white blood cell count

    • Inflammation
    • Inflammation and immune response
    • Hydroxychloroquine

     

    Will convalescent plasma help COVID-19 patients?

    Since the Covid-19 struck the human kind, Medical community is anxiously awaiting a confirmed treatment against this pandemic.

    Research is going on across the world and it seems that a distinct winner will emerge sooner than later.

    But one of the treatments being talked about is “Convalescent plasma” treatment.

    Recently Kerala has got the approval from ICMR to start its use as well.

    • What is convalescent plasma?
    • How does it work?
    • What is the correct stage to conduct this treatment?
    • So what are the current issues?
    • What is the future?

     

    RT-PCR only confirmatory test, says government

    The government has said that the Reverse Transcription-Polymerase Chain Reaction (RT-PCR) is the only standard for the COVID 19 tests and rapid antibody test cannot replace it.

    RT-PCR Test: Basics Advantage of PCR Test over Rapid-Antibody Testing

      

    Govt. nod mandatory for FDI from neighbouring countries

    The outbreak of COVID-19 has adversely affected various firms in India. The Share prices of most of the Indian companies have been falling because of the disruption. The decrease in the share prices has in turn exposed the Indian companies to hostile and opportunistic take over by Chinese Companies.

    Recently, Chinese Central Bank brought 1.75 crore shares of HDFC Bank leading to increase in its ownership from 0.8% to 1.01% of the total shareholding of HDFC. Hence, in order to prevent the hostile takeovers of Indian Companies by foreign Companies, the Government of India has tweaked the FDI Policy.

    • Understanding Foreign Direct Investment
    • Present FDI Policy
    • Sectors where FDI is prohibited
    • Recent Changes:
    • List of Important Sectors and the status of FDI
    Comments

    Jagan Parthiban 2 months ago

    Dear Sir,

    As per the understanding from the discussion,100 % FDI investment was allowed in "Single branded Retail". Hence answer should be option C for Question Number 4. 

    Kind Regards,

    Jagan Parthiban

    Amit Sable 2 months ago

    Answer should be c Please check